Literature DB >> 24323376

Dynamic contrast-enhanced MRI evaluation of cerebral cavernous malformations.

Blaine L Hart1, Saeid Taheri, Gary A Rosenberg, Leslie A Morrison.   

Abstract

The aim of this study is to quantitatively evaluate the behavior of CNS cavernous malformations (CCMs) using a dynamic contrast-enhanced MRI (DCEMRI) technique sensitive for slow transfer rates of gadolinium. The prospective study was approved by the institutional review board and was HIPPA compliant. Written informed consent was obtained from 14 subjects with familial CCMs (4 men and 10 women, ages 22-76 years, mean 48.1 years). Following routine anatomic MRI of the brain, DCEMRI was performed for six slices, using T1 mapping with partial inversion recovery (TAPIR) to calculate T1 values, following administration of 0.025 mmol/kg gadolinium DTPA. The transfer rate (Ki) was calculated using the Patlak model, and Ki within CCMs was compared to normal-appearing white matter as well as to 17 normal control subjects previously studied. All subjects had typical MRI appearance of CCMs. Thirty-nine CCMs were studied using DCEMRI. Ki was low or normal in 12 lesions and elevated from 1.4 to 12 times higher than background in the remaining 27 lesions. Ki ranged from 2.1E-6 to 9.63E-4 min(-1), mean 3.55E-4. Normal-appearing white matter in the CCM patients had a mean Ki of 1.57E-4, not statistically different from mean WM Ki of 1.47E-4 in controls. TAPIR-based DCEMRI technique permits quantifiable assessment of CCMs in vivo and reveals considerable differences not seen with conventional MRI. Potential applications include correlation with biologic behavior such as lesion growth or hemorrage, and measurement of drug effects.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24323376      PMCID: PMC3939060          DOI: 10.1007/s12975-013-0285-y

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  24 in total

1.  Error reduction and parameter optimization of the TAPIR method for fast T1 mapping.

Authors:  M Zaitsev; S Steinhoff; N J Shah
Journal:  Magn Reson Med       Date:  2003-06       Impact factor: 4.668

2.  Prospective follow-up of 33 asymptomatic patients with familial cerebral cavernous malformations.

Authors:  P Labauge; L Brunereau; S Laberge; J P Houtteville
Journal:  Neurology       Date:  2001-11-27       Impact factor: 9.910

3.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations.

Authors:  C S Patlak; R G Blasberg
Journal:  J Cereb Blood Flow Metab       Date:  1985-12       Impact factor: 6.200

4.  Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations.

Authors:  R E Clatterbuck; C G Eberhart; B J Crain; D Rigamonti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

5.  Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging.

Authors:  James M Provenzale; Gin R Wang; Thomas Brenner; Jeffrey R Petrella; A Gregory Sorensen
Journal:  AJR Am J Roentgenol       Date:  2002-03       Impact factor: 3.959

6.  Patlak plots of Gd-DTPA MRI data yield blood-brain transfer constants concordant with those of 14C-sucrose in areas of blood-brain opening.

Authors:  James R Ewing; Robert A Knight; Tavarekere N Nagaraja; John S Yee; Vijaya Nagesh; Polly A Whitton; Lian Li; Joseph D Fenstermacher
Journal:  Magn Reson Med       Date:  2003-08       Impact factor: 4.668

7.  Natural history of the cavernous angioma.

Authors:  J R Robinson; I A Awad; J R Little
Journal:  J Neurosurg       Date:  1991-11       Impact factor: 5.115

8.  The natural history of familial cavernous malformations: results of an ongoing study.

Authors:  J M Zabramski; T M Wascher; R F Spetzler; B Johnson; J Golfinos; B P Drayer; B Brown; D Rigamonti; G Brown
Journal:  J Neurosurg       Date:  1994-03       Impact factor: 5.115

9.  Natural history of intracranial cavernous malformations.

Authors:  T Aiba; R Tanaka; T Koike; S Kameyama; N Takeda; T Komata
Journal:  J Neurosurg       Date:  1995-07       Impact factor: 5.115

10.  Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study.

Authors:  Rustam Al-Shahi Salman; Julie M Hall; Margaret A Horne; Fiona Moultrie; Colin B Josephson; Jo J Bhattacharya; Carl E Counsell; Gordon D Murray; Vakis Papanastassiou; Vaughn Ritchie; Richard C Roberts; Robin J Sellar; Charles P Warlow
Journal:  Lancet Neurol       Date:  2012-01-31       Impact factor: 44.182

View more
  15 in total

Review 1.  Cavernous angiomas: deconstructing a neurosurgical disease.

Authors:  Issam A Awad; Sean P Polster
Journal:  J Neurosurg       Date:  2019-07-01       Impact factor: 5.115

Review 2.  Cerebrovascular disorders associated with genetic lesions.

Authors:  Philipp Karschnia; Sayoko Nishimura; Angeliki Louvi
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

3.  Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations.

Authors:  Romuald Girard; Maged D Fam; Hussein A Zeineddine; Huan Tan; Abdul Ghani Mikati; Changbin Shi; Michael Jesselson; Robert Shenkar; Meijing Wu; Ying Cao; Nicholas Hobson; Henrik B W Larsson; Gregory A Christoforidis; Issam A Awad
Journal:  J Neurosurg       Date:  2016-08-05       Impact factor: 5.115

4.  Effect of Simvastatin on Permeability in Cerebral Cavernous Malformation Type 1 Patients: Results from a Pilot Small Randomized Controlled Clinical Trial.

Authors:  Marc C Mabray; Arvind Caprihan; Jeffrey Nelson; Charles E McCulloch; Atif Zafar; Helen Kim; Blaine L Hart; Leslie Morrison
Journal:  Transl Stroke Res       Date:  2019-10-23       Impact factor: 6.829

5.  Vascular permeability in cerebral cavernous malformations.

Authors:  Abdul G Mikati; Omaditya Khanna; Lingjiao Zhang; Romuald Girard; Robert Shenkar; Xiaodong Guo; Akash Shah; Henrik B W Larsson; Huan Tan; Luying Li; Matthew S Wishnoff; Changbin Shi; Gregory A Christoforidis; Issam A Awad
Journal:  J Cereb Blood Flow Metab       Date:  2015-05-13       Impact factor: 6.200

6.  Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH).

Authors:  Sean P Polster; Ying Cao; Timothy Carroll; Kelly Flemming; Romuald Girard; Daniel Hanley; Nicholas Hobson; Helen Kim; James Koenig; Janne Koskimäki; Karen Lane; Jennifer J Majersik; Nichol McBee; Leslie Morrison; Robert Shenkar; Agnieszka Stadnik; Richard E Thompson; Joseph Zabramski; Hussein A Zeineddine; Issam A Awad
Journal:  Neurosurgery       Date:  2019-04-01       Impact factor: 4.654

7.  Phantom validation of quantitative susceptibility and dynamic contrast-enhanced permeability MR sequences across instruments and sites.

Authors:  Nicholas Hobson; Sean P Polster; Ying Cao; Kelly Flemming; Yunhong Shu; John Huston; Chandra Y Gerrard; Reed Selwyn; Marc Mabray; Atif Zafar; Romuald Girard; Julián Carrión-Penagos; Yu Fen Chen; Todd Parrish; Xiaohong Joe Zhou; James I Koenig; Robert Shenkar; Agnieszka Stadnik; Janne Koskimäki; Alexey Dimov; Dallas Turley; Timothy Carroll; Issam A Awad
Journal:  J Magn Reson Imaging       Date:  2019-09-12       Impact factor: 4.813

8.  Increased number of white matter lesions in patients with familial cerebral cavernous malformations.

Authors:  M J Golden; L A Morrison; H Kim; B L Hart
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-02       Impact factor: 3.825

Review 9.  Neurovascular Unit: Basic and Clinical Imaging with Emphasis on Advantages of Ferumoxytol.

Authors:  Joao Prola Netto; Jeffrey Iliff; Danica Stanimirovic; Kenneth A Krohn; Bronwyn Hamilton; Csanad Varallyay; Seymur Gahramanov; Heike Daldrup-Link; Christopher d'Esterre; Berislav Zlokovic; Haris Sair; Yueh Lee; Saeid Taheri; Rajan Jain; Ashok Panigrahy; Daniel S Reich; Lester R Drewes; Mauricio Castillo; Edward A Neuwelt
Journal:  Neurosurgery       Date:  2018-06-01       Impact factor: 4.654

10.  A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH).

Authors:  Romuald Girard; Yan Li; Agnieszka Stadnik; Robert Shenkar; Nicholas Hobson; Sharbel Romanos; Abhinav Srinath; Thomas Moore; Rhonda Lightle; Abdallah Shkoukani; Amy Akers; Timothy Carroll; Gregory A Christoforidis; James I Koenig; Cornelia Lee; Kristina Piedad; Steven M Greenberg; Helen Kim; Kelly D Flemming; Yuan Ji; Issam A Awad
Journal:  Neurosurgery       Date:  2021-02-16       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.